Regulatory inspections are essential for maintaining compliance in pharmaceutical, biotechnology, and medical device companies. These inspections ensure products meet quality, safety, and efficacy standards. Agencies like the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and Notified Bodies under the EU MDR/IVDR conduct routine and for-cause inspections to verify adherence to Good Manufacturing Practices (GMP), Good Clinical Practices (GCP), and Quality Management System (QMS) requirements.
Failing an inspection can result in warning letters, product recalls, delayed approvals, or even facility shutdowns. That’s why proactive preparation is crucial. Companies must maintain ongoing compliance, conduct internal audits, and train staff to stay inspection-ready. Understanding what inspectors look for, how to manage the process, and how to respond to findings is key to avoiding serious outcomes and ensuring business continuity.
This 60-minute webinar offers a practical guide to help you prepare for inspections by the FDA, EMA, and Notified Bodies. It begins with an overview of each agency’s inspection approach and key focus areas. Then, it covers real-world strategies—like running internal audits, training staff, and organizing documentation.
You’ll also learn how to confidently manage inspections, from hosting auditors and handling document requests to answering questions effectively. The session concludes with steps for post-inspection follow-up, including addressing findings, implementing corrective actions, and sustaining compliance. With expert insights and actionable tips, this webinar equips life science professionals to handle regulatory inspections with confidence and success.
Area Covered in the Session:-
I. Introduction (5 minutes)
II. Understanding Regulatory Inspections (10 minutes)
III. Pre-Inspection Preparation (15 minutes)
IV. Managing the Inspection Process (15 minutes)
V. Post-Inspection Follow-Up (10 minutes)
Why You Should Attend:-
Participants should attend this training to gain a clear and practical understanding of how regulatory inspections are conducted by the FDA, EMA, and Notified Bodies. Being well-prepared is essential, as these inspections can greatly impact a company’s compliance status, product approvals, and reputation.
This session offers valuable insights into common compliance mistakes, how to prepare effectively before an inspection, and the best ways to handle auditors and respond to their findings. Attendees will also learn how to improve internal audit processes, organize documentation more effectively, and take a proactive approach to compliance. By the end of the training, participants will be better equipped to reduce the risk of non-compliance and improve inspection outcomes for their organization.
Who Will Benefit:-
* Download the Order Form
* For 6+ attendees call us at + 1 (844) 449-0244 or mail us at cs@currentwebinar.com
Integrating AI and ChatGPT into Project Management for Better FDA Compliance
Navigating FDA Inspections Successfully - Most Common Observations and Prevention Strategies
Excel Spreadsheet Validation for Part 11 to Eliminate 483s
Excel Spreadsheets; Ensuring Data Integrity and 21 CFR Part 11 Compliance 2025
Charles H. Paul is the President of C. H. Paul Consulting, Inc. – a regulatory, training, and technical documentation consulting firm. Charles has been a regulatory consultant to the life sciences industry for over 20 years and has published numerous white papers on the subject. The firm works with both domestic and international clients designing solutions for complex human performance and compliance-related problems.